Provided by Johnson Winter Slattery
Johnson Winter Slattery provides cutting-edge advice for healthcare and life sciences innovators on the full spectrum of regulatory and commercial issues inherent in transactional and contentious matters.
JWS advises an extensive list of leading clients, including biotechnology, medical device developers and suppliers, medtech and pharmaceutical clients. They have deep industry expertise to help clients navigate these heavily regulated industries with specialist advice that they tailor to the concerns of emerging technological and commercial needs.
JWS assists clients in commercialising bioscience products in Australia, from supporting with clinical trial documentation to guiding clients on the compliant promotion and advertising of therapeutic goods.
The regulatory team handles privacy and health records issues, ensuring patient consent and managing data breach obligations. JWS provides an integrated service, with its regulatory, commercial, tax and dispute resolution teams collaborating to advise its clients.
Provided by Chambers
Johnson Winter Slattery has a strong IP and life sciences practice. The team is often called upon by major medical device and pharmaceutical corporations for its expertise in patent applications, litigation and financing.
Christine Ecob is a key contact at the firm.
JWS was engaged by CurveBeam AI to assist with preparing and negotiating an
exclusive commercial referral agreement with Stryker Australia for the
territories of Australia and New Zealand.
Provided by Chambers
Johnson Winter Slattery offers a combination of approachability, reliability and excellence in execution that sets them apart and makes them a trusted and valued partner.
The team at JWS has rich experience in the medical device sector both locally and internationally.
Johnson Winter Slattery offers a combination of approachability, reliability and excellence in execution that sets them apart and makes them a trusted and valued partner.
The team at JWS has rich experience in the medical device sector both locally and internationally.